Electrical Impedance Tomography-derived Flow Index During Spontaneous Breathing Trial Stratifies the Risk of Reintubation Within 48 h After Extubation
EIT-FI Weaning
1 other identifier
observational
150
1 country
3
Brief Summary
Accurate prediction of readiness to liberate patients from mechanical ventilation remains challenging. Conventional indices such as the rapid shallow breathing index (RSBI) and maximal inspiratory pressure (MIP) often miss early signs of injurious breathing patterns or regional ventilation asynchrony that can lead to extubation failure. Electrical impedance tomography (EIT) provides continuous, non-invasive imaging of regional lung ventilation. We developed a novel EIT-derived Flow Index (FI) which integrates the magnitude of inspiratory effort with the temporal synchrony of lung filling. This prospective, multicenter observational study aimed to (1) validate the predictive value of FI during spontaneous breathing trials (SBT) compared with conventional weaning indices, and (2) compare the predictive ability of EFI with traditional weaning indices(RSBI,MIP,P0.1).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2024
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2024
CompletedFirst Submitted
Initial submission to the registry
March 10, 2025
CompletedFirst Posted
Study publicly available on registry
March 14, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedApril 23, 2026
December 1, 2025
1.1 years
March 10, 2025
April 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Spontaneous Breathing Trial (SBT) Success Rate
Proportion of patients who complete the 30-minute Spontaneous Breathing Trial (SBT) without signs of respiratory distress, hypoxemia, or hemodynamic instability.
Within 30 minutes of Spontaneous Breathing Trial (SBT)
Secondary Outcomes (6)
Reintubation Rate within 48 hours
Within 48 hours after extubation.
Ventilator-Free Days by Day 7
Within 7 days after extubation.
ICU Mortality
during the ICU stay or within 24 hours following transfer out of the ICU
Reintubation rate within 48 hours after extubation
within the 48 hours after extubation
Ventilator-Free Days at Day 7 (VFD-7)
Within 7 days after extubation
- +1 more secondary outcomes
Study Arms (1)
Conventional method Respiratory Drive group
Conventional method Respiratory Drive group(Methods include: esophageal pressure monitoring, airway obstruction pressure (P0.1) )
Interventions
Respiratory drive assessed by flow index measured by electrical impedance tomography.
Eligibility Criteria
1. 150 critically ill patients requiring respiratory support were planned for inclusion 2. Age ≥18 years 3. Gender is not limited 4. Patients with expected duration of respiratory support \>24 hours
You may qualify if:
- Age ≥18 years
- Acute respiratory failure requiring intubation and mechanical ventilation ≥48 hours
- Hemodynamic stability (no escalation of vasoactive agents)
- Oxygenation: FiO₂ ≤0.5, PEEP ≤8 cmH₂O
- Meeting standard ICU criteria for SBT readiness
You may not qualify if:
- Neuromuscular diseases impairing spontaneous breathing
- High cervical spinal cord injury
- Deep sedation (RASS ≤-3)
- Inadequate EIT signal quality
- Contraindications to EIT
- Pregnancy
- Expected survival \<24 h
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ruijin Hospitallead
- Fujian Provincial Hospitalcollaborator
- Peking Union Medical College Hospitalcollaborator
Study Sites (3)
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
Fujian Provincial Hospital
Fuzhou, Fujian, 200025, China
Department of Critical Care Medicine,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China.
Shanghai, 200025, China
Study Officials
- STUDY CHAIR
Hongping Qu
Department of Critical Care Medicine,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine
- STUDY DIRECTOR
Jialin Liu
Department of Critical Care Medicine,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine
- PRINCIPAL INVESTIGATOR
rui zhang
Department of Critical Care Medicine,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 10, 2025
First Posted
March 14, 2025
Study Start
December 1, 2024
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
April 23, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation